These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21831500)

  • 1. [Molecular staging and prognosis in lung cancer].
    Sánchez de Cos Escuín J
    Arch Bronconeumol; 2011 Nov; 47(11):539-40. PubMed ID: 21831500
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 3. The coming of age of molecular tumor profiling.
    Antonoff MB; D'Cunha J
    Semin Thorac Cardiovasc Surg; 2011; 23(1):8-9. PubMed ID: 21807290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining prognosis in non-small-cell lung cancer.
    Singh T; Dhindsa J
    N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited commentary.
    Pfannschmidt J
    Ann Thorac Surg; 2010 Feb; 89(2):380. PubMed ID: 20103302
    [No Abstract]   [Full Text] [Related]  

  • 6. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1071-87. PubMed ID: 18070704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.
    Wicha MS; Hayes DF
    J Clin Oncol; 2011 Apr; 29(12):1508-11. PubMed ID: 21422428
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular biologic staging of lung cancer.
    D'Amico TA
    Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
    Mitra AP; Lin H; Cote RJ; Datar RH
    Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First clinically useful marker for lung cancer identified.
    Oncology (Williston Park); 2003 May; 17(5):737-8. PubMed ID: 12800797
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ERCC1 and lung cancer].
    Planchard D; Olaussen KA; Soria JC
    Rev Mal Respir; 2010 Apr; 27(4):387-94. PubMed ID: 20403548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future in diagnosis and staging of lung cancer. Molecular techniques.
    Sienel W; Dango S; Ehrhardt P; Eggeling S; Kirschbaum A; Passlick B
    Respiration; 2006; 73(5):575-80. PubMed ID: 17008784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue.
    Joshi MB; D'Amico TA; Harpole DH
    Methods Mol Med; 2003; 75():369-88. PubMed ID: 12407753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchial cancer--adjuvant chemotherapy].
    Drings P
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():89-94. PubMed ID: 1983675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers in the adjuvant therapy of non-small cell lung cancer.
    Filipits M; Pirker R
    Lung Cancer; 2011 Dec; 74(3):355-63. PubMed ID: 21885151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging and the selection of therapy for non-small cell lung cancer.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
    Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
    Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of non-small-cell lung cancer.
    Hadeed VA; Jett JR
    Compr Ther; 1996 Oct; 22(10):641-8. PubMed ID: 8950080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.